{
  "id": "clinical#screening_cues_214970dd",
  "content": "tamol) that is presumed to be causing the anxiety symptoms. The\ndiagnostic code is selected from the table included in the criteria set,\nwhich is based on the drug class. For substances that do not fit into\nany of the classes (e.g., salbutamol), the code for “other substance”\nshould be used; and in cases in which a substance is judged to be an\netiological factor but the specific class of substance is unknown, the\ncategory “unknown substance” should be used.\nThe name of the disorder is followed by the specification of onset\n(i.e., onset during intoxication, onset during withdrawal, onset during\nmedication use). Unlike the recording procedures for ICD-10-CM,\nwhich combine the substance-induced disorder and substance use dis-\norder into a single code, for ICD-9-CM a separate diagnostic code is\ngiven for the substance use disorder. For example, in the case of anxiety\nsymptoms occurring during withdrawal in a man with a severe loraze-\npam use disorder, the diagnosis is 292.89 lorazepam-induced anxiety\ndisorder, with onset during withdrawal. An additional diagnosis of\n304.10 severe lorazepam use disorder is also given. When more than one\nsubstance is judged to play a significant role in the development of anx-",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues tamol) that is presumed to be causing the anxiety symptoms. The\ndiagnostic code is selected from the table included in the criteria set,\nwhich is based on the drug class. For substances that do not fit into\nany of the classes (e.g., salbutamol), the code for “other substance”\nshould be used; and in cases in which a substance is judged to be an\netiological factor but the specific class of substance is unknown, the\ncategory “unknown substance” should be used.\nThe name of the disorder is followed by the specification of onset\n(i.e., onset during intoxication, onset during withdrawal, onset during\nmedication use). Unlike the recording procedures for ICD-10-CM,\nwhich combine the substance-induced disorder and substance use dis-\norder into a single code, for ICD-9-CM a separate diagnostic code is\ngiven for the substance use disorder. For example, in the case of anxiety\nsymptoms occurring during withdrawal in a man with a severe loraze-\npam use disorder, the diagnosis is 292.89 lorazepam-induced anxiety\ndisorder, with onset during withdrawal. An additional diagnosis of\n304.10 severe lorazepam use disorder is also given. When more than one\nsubstance is judged to play a significant role in the development of anx- Tamol) that is presumed to be causing the lo âu symptoms. the\ndiagnostic code is selected from the table included in the criteria set,\nwhich is based on the drug class."
}